This is a combination of two research peptides that affect different signals involved in growth-hormone release. The combination itself has limited high-quality human evidence.

CJC-1295 / Ipamorelin
This is a combination of two research peptides that affect different signals involved in growth-hormone release. The combination itself has limited high-quality human evidence.
Peptide class: GHRH analogue and ghrelin-receptor agonist combination
OVERVIEW
CJC-1295 / Ipamorelin (10 mg) is listed in the muscle growth & performance collection. A combination of a growth-hormone-releasing-hormone analogue and a ghrelin-receptor agonist.
The two components are investigated for separate signals involved in pituitary growth-hormone release; combined effects cannot be assumed from studies of either alone. This product is presented for research and educational discussion; the listed vial should not be assumed equivalent to a clinically studied or approved formulation.
Laboratory investigations consider GHRH and ghrelin receptor pathways and related biological systems. Interpretation depends on the compound identity, study design and the quality of the available evidence.
POTENTIAL RESEARCH BENEFITS
CJC-1295 / Ipamorelin is examined for potential research relevance in the following areas. These are topics of investigation, not demonstrated benefits of the listed product:
GHRH receptor signaling
Researchers explore ghrh receptor signaling in appropriate laboratory, preclinical or clinical study settings, where available. The findings should not be interpreted as a guaranteed outcome.
Ghrelin receptor signaling
Researchers explore ghrelin receptor signaling in appropriate laboratory, preclinical or clinical study settings, where available. The findings should not be interpreted as a guaranteed outcome.
Growth-hormone secretory pathways
Researchers explore growth-hormone secretory pathways in appropriate laboratory, preclinical or clinical study settings, where available. The findings should not be interpreted as a guaranteed outcome.
MECHANISM OF ACTION
The two components are investigated for separate signals involved in pituitary growth-hormone release; combined effects cannot be assumed from studies of either alone.
The primary area of scientific interest involves GHRH and ghrelin receptor pathways. Proposed effects and their significance may vary by experimental model and have not necessarily been demonstrated in humans.
PRODUCT SPECIFICATIONS
- Compound name: CJC-1295 / Ipamorelin
- Product classification: GHRH analogue and ghrelin-receptor agonist combination
- Listed size / format: 10 mg
- Research category: Muscle Growth & Performance
- Molecular weight / sequence: Consult compound-specific technical documentation; not verified for this listing
- Appearance / purity: Confirm from batch-specific certificate of analysis, if available
What is CJC-1295 / Ipamorelin?
CJC-1295 / Ipamorelin is a ghrh analogue and ghrelin-receptor agonist combination investigated in the context of GHRH and ghrelin receptor pathways.
What is CJC-1295 / Ipamorelin commonly researched for?
Research areas include ghrh receptor signaling, ghrelin receptor signaling, growth-hormone secretory pathways.
The combination lacks adequate controlled clinical evidence for broad performance claims.
Product Info
Shipping & Processing
Return & Refund Policy
Information for scientific context only. No dosing, treatment or administration instructions.
Understanding CJC-1295 / Ipamorelin
A clear, everyday-language guide to what this product is and why it interests researchers.
Research peptide or compound
The exact contents and quality of this listing need product-specific documentation.
Growth-hormone signals
What researchers are exploring
Three simple ways to understand the science behind this product.
Growth-hormone signals
Scientists look at how each peptide interacts with the body’s natural growth-hormone signaling system.
What scientists are looking at
Studies look for measurable changes under controlled conditions. Results can depend on the exact ingredient and study design.
What we still need to learn
Early findings do not automatically mean a product is safe or effective for people. More reliable human research may be needed.
The idea, in plain English
Scientists look at how each peptide interacts with the body’s natural growth-hormone signaling system. That is the research idea, not a promise that the same effect will happen in a person.
What is known — and unknown
The individual peptides have been studied, but there is not strong evidence that the combination improves muscle growth, recovery or sleep in people.
A study on one ingredient or approved medicine does not automatically prove the same results for a different product. The exact ingredients, quality and testing matter.
The simple takeaway
This is a combination of two research peptides that affect different signals involved in growth-hormone release. The combination itself has limited high-quality human evidence. Research interest does not guarantee a benefit, and the exact product should be evaluated on its own evidence.
This information is not medical advice and does not establish that this product is approved, safe or effective for any medical use. No purity, sterility, third-party testing or manufacturing certification is claimed without documentation. Consult qualified professionals and applicable regulators.
More questions?
We’re here to help.
Ask our team about the listed product information or return to the complete collection.
Let's Connect